Related by context. All words. (Click for frequent words.) 66 intravenous bisphosphonates 64 severe hypersensitivity reactions 63 HMG CoA reductase inhibitors 63 headache abdominal pain 62 ABCB1 62 leukopenia pancytopenia thrombocytopenia 61 Hypersensitivity reactions 61 Itraconazole 61 myelodysplastic myeloproliferative diseases 61 TNF blocker therapy 61 Leukemias 61 KETEK 61 danazol 61 hyperprolactinemia 60 colorectal adenocarcinoma 60 nonhematologic adverse reactions 60 Ischemic 60 hypereosinophilic syndrome 60 CYP #A# 60 pharmacokinetic interactions 59 hepatotoxicity 59 abdominal adiposity 59 Gabapentin enacarbil 59 rheumatoid arthritis osteoarthritis ankylosing 59 erythropoietic 59 H2 antagonists 59 vasoactive 59 Leydig cell 59 headache nasopharyngitis 59 primidone 59 administered concomitantly 59 Pegylated 59 haematopoietic 59 norfloxacin 59 CP CPPS 59 Vectical 59 Antitumor Activity 58 ALVESCO 58 COPEGUS R 58 gabapentin Neurontin 58 vascular endothelial 58 TNF Tumor Necrosis Factor 58 myeloproliferative 58 synovial 58 Oral corticosteroids 58 Methylnaltrexone 58 oxcarbazepine 58 Tasigna prolongs 58 Known hypersensitivity 58 hematological parameters 58 CIMZIA R 58 ACTOplus met XR 58 FUSILEV enhances 58 CYP #D# 58 Investigational Treatment 58 posaconazole 58 pathophysiological effects 58 myopathies 58 ARCALYST ® 58 CCR5 delta# 57 Peginterferon alfa 2b 57 amprenavir 57 Eculizumab 57 TNF receptor 57 R lenalidomide 57 hypercalcemia 57 Coadministration 57 chronic periodontitis 57 weekly subcutaneous injections 57 Mesalamine 57 CYT# potent vascular disrupting 57 myopathy rhabdomyolysis 57 Hepatic Impairment 57 Aliskiren 57 serum BDNF 57 IMiDs ® 57 RoACTEMRA 57 factor TNF 57 conventional DMARDs 57 INVANZ 57 nonbacterial prostatitis 57 PEGylated anti 57 docetaxel Taxotere ® 57 sotalol 57 atherothrombotic 57 Cariprazine 57 soluble TNF receptor 56 neoplastic diseases 56 bronchopulmonary dysplasia BPD 56 Estrogen deficiency 56 Darinaparsin 56 Golimumab 56 Abrupt discontinuation 56 Certolizumab pegol 56 immunomodulatory effects 56 renal toxicity 56 Gemzar ® 56 aripiprazole Abilify 56 peginterferon alfa 56 Exacerbations 56 lenalidomide Revlimid R 56 nitrotyrosine 56 VAPRISOL 56 Anthracyclines 56 angiotensin converting enzyme inhibitor 56 anti androgen 56 mucosal inflammation 56 ® lenalidomide 56 TNF alpha selectively neutralizing 56 catheter occlusion 56 tiotropium bromide 56 nonsteroidal anti inflammatories 56 VA# [002] 56 VP# [004] 56 paraneoplastic 56 neurological manifestations 56 hepatotoxic 56 beta lactam antibiotic 56 riociguat 56 rheumatic disorders 56 prostate carcinogenesis 56 novel VDA molecule 56 BPH benign prostatic 56 piroxicam 56 cardiotoxic 56 COX2 56 MDR1 56 CIMZIA ™ 56 Toxicities 56 leflunomide 56 osteoclast 56 LATUDA 55 panitumumab Vectibix 55 evaluating tivozanib 55 imatinib resistance 55 HER2 overexpression 55 Proquin XR 55 Hypokalemia 55 APTIVUS r 55 Pemetrexed 55 INTEGRILIN 55 Ophena TM 55 PEGylated Fab fragment 55 tegaserod 55 Panzem R 55 ciprofloxacin hydrochloride 55 PON1 gene 55 INCB# [003] 55 Cancidas 55 antiresorptive 55 neutropenia dehydration dyspnea 55 BRAF V#E 55 MDS MPD 55 renal fibrosis 55 oral antidiabetic medication 55 immunosuppressant drug 55 Teriflunomide 55 etiologic 55 calcineurin inhibitors 55 pleiotropic effects 55 serum homocysteine 55 adipokines 55 serum leptin 55 HGS ETR1 mapatumumab 55 deletion 5q 55 teratogenic effects 54 metformin sulfonylurea 54 AGILECT R 54 hypothalamic pituitary adrenal axis 54 plasma pharmacokinetics 54 soluble tumor necrosis 54 O PPDS 54 sodium stibogluconate 54 S/GSK# 54 recurrent glioblastoma multiforme 54 antineoplastic 54 anticancer activity 54 SMAD4 54 lenalidomide dexamethasone 54 symptomatic hyponatremia 54 comorbid depression 54 selective modulator 54 experimental autoimmune encephalomyelitis 54 decompensated liver disease 54 lymphoproliferative disorders 54 unstable angina pectoris 54 AZT zidovudine 54 Parkinson disease levodopa induced 54 interferon alfa 2b 54 ZOMETA 54 Antiangiogenic 54 5mg dose 54 NMDA antagonists 54 monoamine oxidase inhibitors 54 COL#A# 54 Fibroblast 54 GnRH agonist 54 Sebivo 54 itraconazole 54 tiagabine 54 chronic lyme 54 Pharmacokinetics PK 54 serotonin reuptake 54 CYP#A# inhibitors 54 thienopyridines 54 DORIBAX 54 neurocognitive deficits 54 Zoledronic acid 54 acyclovir Lauriad R 54 erlotinib Tarceva ® 54 Emtriva Viread 54 effector function 54 neoplastic 54 fluoroquinolone antibiotic 54 PD LID 53 Sodium oxybate 53 valtorcitabine 53 propranolol Inderal 53 alkylating agents 53 CK # administered 53 airway hyperresponsiveness 53 TMPRSS2 ERG 53 Xyrem ® 53 serious cardiovascular thrombotic 53 ARICEPT R 53 reactogenicity 53 shorter telomere length 53 #HT#A 53 PKC# 53 severe renal impairment 53 cardiovascular calcification 53 Paxil paroxetine 53 Tibotec Therapeutics division 53 lipoprotein metabolism 53 adriamycin 53 Perforomist ™ Inhalation Solution 53 aromatase inhibitors AIs 53 taxane resistant 53 Angiotensin converting enzyme 53 platelet activation 53 ritonavir boosted 53 therapeutically inactive prodrug 53 NS4A 53 oral mTOR inhibitor 53 R adalimumab 53 INVEGA ® 53 Genetic variation 53 canakinumab 53 muscarinic receptors 53 receptor inhibitor 53 multivariate adjustment 53 lymphangiogenesis 53 Erythropoietic 53 ERalpha 53 Sitagliptin 53 Combination therapy 53 insulin sensitizing drug 53 glucose abnormalities 53 Belimumab 53 bladder carcinoma 53 biochemical abnormalities 53 pegylated liposomal doxorubicin 53 DEXILANT 53 metformin hydrochloride 53 QVAR ® 53 Eszopiclone 53 Adalimumab 53 MTP inhibitor 52 Tolvaptan 52 polymicrobial 52 alexithymia 52 HIV HCV coinfected 52 refractory unresponsive 52 ACTEMRA TM 52 abacavir lamivudine 52 proapoptotic 52 Gleevec resistant 52 5 HT6 receptor 52 Thiovir 52 p#Kip# 52 saquinavir ritonavir 52 doxorubicin Adriamycin 52 BoNTA 52 patients coinfected 52 clinicopathologic 52 hereditary deficiency 52 prochlorperazine 52 systemically absorbed 52 DOXIL 52 pimozide 52 urocortin 2 52 octreotide acetate 52 factor TNF receptor 52 LT NS# 52 estramustine 52 hepatic insufficiency 52 Navelbine ® 52 Vidofludimus 52 Vildagliptin 52 CB2 receptor 52 TP# mutations 52 prospectively stratified 52 receptor subtypes 52 NUCYNTA R 52 adrenocortical 52 Forodesine HCl 52 cytopathic 52 Budesonide foam crofelemer 52 serotonergic 52 Macrophage 52 histone deacetylase inhibitor 52 PROCRIT 52 HCV RNA polymerase 52 Telmisartan 52 parkinsonian symptoms 52 plus methotrexate 52 plus prednisone prednisolone 52 dopamine D2 52 beta agonists 52 Traficet EN 52 bortezomib Velcade 52 receptor tyrosine kinase inhibitor 52 HLA DRB1 * 52 oral prodrug 52 Quetiapine 52 Monotherapy 52 TNF antagonists 52 CpG DNA 52 Certolizumab 52 EBV infection 52 CIMZIA TM 52 Sandostatin 52 Vasopressin 52 cisplatin gemcitabine 52 EGFR tyrosine kinase inhibitors 52 AVELOX 52 comorbid disorders 52 cAMP signaling 51 pegylated interferon alfa 51 #HT#A receptor 51 serum estradiol 51 fasting plasma 51 alpha 2a 51 nonsteroidal 51 humanized interleukin 6 51 pleiotropic 51 ISTODAX 51 proguanil 51 coinfected patients 51 familial clustering 51 selective antagonist 51 p# activation 51 endothelin receptor antagonists 51 ocular adverse 51 surgical prophylaxis 51 CAELYX 51 rilpivirine 51 Angiotensin receptor blockers 51 ABCB1 gene 51 sunitinib Sutent ® 51 functional polymorphism 51 immunomodulating 51 antiapoptotic 51 gemfibrozil 51 favorable tolerability 51 endogenous ligands 51 lesional 51 lopinavir ritonavir plus 51 neuropsychiatric diseases 51 anti arrhythmic drug 51 β1 51 metaglidasen 51 vismodegib 51 immunomodulatory therapy 51 6 mercaptopurine 51 highly purified pasteurized 51 COPEGUS 51 XP# XP# 51 Bystolic nebivolol 51 oxidative DNA 51 attention-deficit/hyperactivity 51 eIF4E 51 Fulvestrant 51 nonstimulant 51 cardiovascular thrombotic 51 KRAS mutational status 51 fibrotic disease 51 Aztreonam lysine 51 dose proportionality 51 impaired glucose metabolism 51 T#M 51 osteoclast formation 51 superficial bladder cancer 51 prospective multicentre 51 potentiation 51 beta actin 51 physiologic mechanisms 51 colesevelam HCl 51 STRIDE PD 51 inflammatory dermatoses 51 Tapentadol 51 euthymic patients 51 ST Segment Elevation 51 cefixime 51 either acutely decompensated 51 systemically administered 51 serologically active systemic lupus 51 hypomethylating agents 51 nucleoside analog 51 coadministration 51 embryonic lethality 51 MenACWY 51 PRISTIQ 51 pseudobulbar affect PBA 51 OMP #R# 51 DNA adducts 51 Fast Track designations 51 Fidaxomicin 51 KIF6 carriers 51 HPA axis 51 BYETTA exenatide injection 51 DQB1 * 51 AZILECT 51 Pagoclone 51 mediated inhibition 51 fluconazole 51 YONDELIS 51 Linagliptin 51 D aspartate NMDA receptor 51 RELISTOR methylnaltrexone bromide 51 5 HT2A receptor 51 specifically hypoactive sexual 51 morphological abnormalities 51 immunosuppressive regimen 51 primary axillary hyperhidrosis 51 PKC inhibitors 51 N methyl 51 dosing frequency 51 cis retinoic acid 51 GSK# [001] 50 urate lowering therapy 50 pegylated 50 prednisone prednisolone 50 ALB # 50 pharmacokinetic interaction 50 ritonavir boosted protease inhibitor 50 MAP kinases 50 mu opioid agonists 50 polymicrobial infections 50 NKG2D 50 experimental allergic encephalomyelitis 50 catenin 50 oral picoplatin 50 interferon γ 50 Adverse events 50 dietary acrylamide 50 protein tyrosine phosphatase 50 LHRH receptors 50 clinicopathological 50 anti resorptive 50 Dysregulation 50 Capesaris 50 active moiety 50 amnestic 50 pharmacodynamic parameters 50 demonstrated antitumor activity 50 adhesion molecule EpCAM 50 Tolerability 50 etiological 50 ketorolac 50 proteasome inhibitor 50 OSAHS 50 RAPAMUNE 50 Fingolimod 50 dopamine partial agonist 50 TIMP 1 50 anthracycline taxane 50 ADAGIO study 50 Tofacitinib 50 visilizumab 50 KAPIDEX 50 peripheral neuropathy CIPN 50 albumin excretion rate 50 clinicopathological features 50 Neuronal 50 PR interval prolongation 50 SLC#A# [002] 50 SUSTENNA TM 50 diabetic peripheral neuropathic DPN 50 peripherally acting 50 potent triglyceride lowering 50 6R BH4 50 Rivaroxaban 50 chromosome #p# [002] 50 TRAIL induced apoptosis 50 NUCYNTA TM 50 unmeasured confounding 50 visceral adiposity 50 agent VDA 50 Paroxetine 50 amphotericin 50 efferent 50 endothelin receptor 50 cetuximab Erbitux ® 50 anthracycline containing 50 CG# [003] 50 pharmacologic therapies 50 serotonin norepinephrine reuptake inhibitor 50 imatinib Gleevec ® 50 desire disorder HSDD 50 malignant pleural effusion 50 Symadex 50 Virulizin ® 50 leukotriene receptor antagonists 50 advanced metastatic renal 50 genetic loci 50 baroreflex 50 GABRA2 50 anterior temporal 50 DLTs 50 ZOMIG 50 Testosterone deficiency 50 acute gout flares 50 dasatinib Sprycel ® 50 risperidone Risperdal 50 motesanib 50 genotype phenotype 50 TNF antagonist therapy 50 known sulfonamide allergy 50 #D#C# 50 deacetylation 50 Endogenous 50 Gefitinib 49 acute bronchospasm 49 doxorubicin cyclophosphamide 49 acute HAE attacks 49 mania hypomania 49 dopamine receptor agonist 49 ADH1B 49 dipropionate 49 imatinib therapy 49 Linaclotide 49 Arranon 49 myelosuppression 49 chemosensitivity 49 T#M mutation 49 parenterally administered 49 tocilizumab 49 periodontal tissues 49 #q# deletion syndrome 49 briakinumab 49 CagA 49 5 HT1A receptor 49 REYATAZ ritonavir 49 Zoraxel 49 overactivation 49 docetaxel Taxotere R 49 Methylphenidate 49 Aflibercept 49 monoamine oxidase inhibitor MAOI 49 HuMax CD4 49 demyelination 49 favorable pharmacokinetic 49 HIF PH 49 analgesic efficacy 49 XL# inhibits 49 neuroendocrine cells 49 albiglutide 49 glucocorticosteroids 49 administered subcutaneously 49 β2 49 azoles 49 LEP ETU 49 #mg BID [003] 49 novel cardiac myosin 49 favorable pharmacokinetic profile 49 injectable formulations 49 EMSAM 49 CTA# Injection 49 inflammatory demyelinating 49 Relapsed Refractory Multiple Myeloma 49 investigational oral inhibitor 49 oral methylnaltrexone 49 CA4P 49 urate lowering 49 dorsomedial 49 8mg/kg 49 Seliciclib 49 idarubicin 49 cytotoxic effects 49 plasma leptin 49 TDF FTC 49 Elacytarabine 49 neurosensory 49 nucleoside analogue 49 Omacetaxine mepesuccinate 49 etiologic factors 49 uric acid lowering 49 NUCYNTA ® 49 axillary node 49 Vincristine 49 lipid homeostasis 49 rCBF 49 neuronal dysfunction 49 Cethromycin 49 functional gastrointestinal disorders 49 severe idiopathic Restless 49 KIACTA ™ 49 HIF 1alpha 49 Schizoaffective Disorder 49 CCR5 antagonist 49 antidepressant efficacy 49 XYZAL ® 49 antenatal depression 49 oral antiviral 49 neuro endocrine 49 HyQ 49 dose dependently 49 PDE# inhibitors 49 TSC1 49 familial predisposition 49 Talactoferrin 49 colesevelam 49 glial tumors 49 taxane refractory 49 Preclinical studies suggest 49 cardiometabolic syndrome 49 Pegasys ® 49 Pruvel 49 Paliperidone Palmitate 49 mitotic catastrophe 49 5 HT2C 49 imatinib resistant 49 didanosine associated 49 systemic immunosuppressive 49 statistically significant predictor 49 neurexins 49 Rasagiline 49 TGF β1 49 GG genotype 49 radiotherapy induced 48 Cytogenetic 48 NOXAFIL Oral Suspension 48 nonhuman primate model 48 coexpression 48 opioid medications 48 familial hypercholesterolemia FH 48 Infliximab 48 glucose homeostasis 48 olanzapine Zyprexa 48 protein rFIXFc 48 Bcl xL 48 differential gene expression 48 oral rivaroxaban 48 refore 48 Prosaptide 48 glutamatergic 48 malarial fevers 48 L. donovani 48 Cerebellar 48 MAO inhibitors 48 Treg cell 48 Luteinizing Hormone Releasing Hormone 48 ARIKACE 48 small molecule tyrosine 48 HERCEPTIN 48 Etiology 48 4mg/kg 48 CYP# [002] 48 coadministered 48 narrow angle glaucoma 48 CHOP chemotherapy 48 echinocandins 48 hypothalamic pituitary adrenal HPA 48 underlying pathophysiology 48 ziprasidone 48 vivo coagulation 48 mGluR5 NAM 48 plasma homocysteine 48 intraobserver 48 emotional lability 48 inherited genetic mutations 48 cytochrome P# #A# 48 Doxepin 48 EGFR antibodies 48 ACE inhibitor ramipril 48 Multiple Ascending Dose 48 selective inverse agonist 48 eltrombopag 48 Fenofibrate 48 cholinergic 48 synuclein 48 psychosocial variables 48 Heritability 48 oral dihydropyrimidine dehydrogenase DPD 48 EMBEDA ™ 48 Duloxetine 48 oral corticosteroid 48 intranasal formulations 48 colorectal carcinogenesis 48 antioxidant supplementation 48 autoregulation 48 synthetic lethality 48 antiarrhythmic drugs 48 DiLA2 liposomes 48 Suicidal ideation 48 microglial 48 ovarian carcinoma 48 standard chemotherapy regimen 48 teriflunomide 48 SEROQUEL XR 48 eculizumab 48 #mg/day [002] 48 PRTX 48 linear pharmacokinetics 48 protease activated 48 serotonin norepinephrine reuptake inhibitors 48 androgen depletion 48 Aclidinium 48 sequestered naltrexone 48 Azedra 48 #β estradiol 48 OPRM1 48 Archexin 48 clonogenic 48 c Src 48 Wyeth Enbrel 48 statistically significant p = 48 potentiated 48 molecular weight heparins 48 carbidopa 48 EFGR 48 LITHE study 48 potentially modifiable 48 mitochondrial oxidative 48 Bezielle 48 dextromethorphan quinidine 48 Pharmacogenetic 48 pharmacodynamic properties 48 Pruvel TM 48 baseline serum bilirubin 48 poststroke depression 48 vascular cognitive impairment 48 tricyclics 48 posterior cingulate 48 CYP#D# inhibitors 47 heterologous expression 47 limiting toxicity DLT 47 nebulized formoterol fumarate 47 HCV protease inhibitors 47 FKBP# 47 Valortim R 47 HES CEL 47 Perforomist TM Inhalation Solution 47 OHR/AVR# 47 hematologic adverse 47 neuronal plasticity 47 TrkB 47 HCD# [002] 47 pleconaril 47 affective psychosis 47 ularitide 47 administered intranasally 47 NKT cell 47 mGluR2 NAM 47 irinotecan doxorubicin oxaliplatin paclitaxel 47 somatic mutation 47 Hematologic toxicity 47 maximally tolerated lipid lowering 47 hepatic stellate cells 47 Meta analyzes 47 ganaxolone 47 proinflammatory cytokine 47 Tarceva TM 47 glycolytic 47 APOE genotype 47 acute exacerbation 47 Arikace 47 opioid agonists legal 47 NV Organon 47 immunological mechanisms 47 thienopyridine 47 neurocognitive function 47 5 HT2A 47 Ribavirin 47 clinically meaningful differences 47 erythropoiesis stimulating agent 47 pemetrexed Alimta 47 anthracycline unless 47 JNK activation 47 impaired cognition 47 microstructural 47 NUEDEXTA 47 fluorouracil leucovorin 47 diabetic neuropathic pain 47 intestinal microflora 47 guanfacine extended release 47 potassium sparing 47 Pruvel ™ 47 Metformin GR 47 somatoform disorders 47 VELCADE melphalan 47 LEXIVA 47 vaccine RiVax TM 47 IntroductionThe 47 guanfacine 47 diathesis 47 Related Anemia 47 TAFA# 47 mg/m2 cohort 47 SNALP technology 47 M1 muscarinic 47 norepinephrine reuptake inhibition 47 AVE# 47 vertebral subluxation 47 neuronal degeneration 47 clinical trials XIFAXAN 47 Voreloxin 47 inhaled iloprost 47 nebulization 47 vagal 47 SSRI citalopram 47 overlapping toxicities 47 Topotecan 47 subcutaneously administered 47 stopping PEGINTRON 47 pyrimidine nucleoside analog 47 Epithelial Cell 47 cystic fibrosis transmembrane 47 milatuzumab 47 tHcy 47 familial aggregation 47 FOLFOX chemotherapy 47 rifampin 47 anti EGFR antibody 47 treating neuropathic pain 47 mucosal immune 47 Enterococcus faecalis 47 Regadenoson 47 CHI#L# 47 Abnormal Uterine Bleeding 47 atypical neuroleptics 47 ™ pralatrexate injection 46 cortical excitability 46 nilotinib Tasigna ® 46 Chemophase 46 Brain derived neurotrophic 46 bacterial virulence 46 Clevudine 46 logistic regression models 46 dopaminergic 46 TNFR1 46 hematological toxicity 46 electrophysiologic 46 pegylated interferon alfa 2a 46 CINOD 46 PULMICORT RESPULES 46 PB1 F2 46 Altabax 46 supine hypertension 46 cannabinor 46 FoxP3 46 CINQUIL 46 FORADIL 46 affective psychoses 46 dermatologic toxicities 46 amyloidogenic 46 KNS # 46 apoptosis inducer 46 ADRB2 46 hENT1 46 clinically contraindicated 46 metformin monotherapy 46 beta1 integrin 46 Nimotuzumab 46 xenobiotic 46 somatization disorder 46 CORLUX CORT # 46 chemotherapeutic agent 46 antidepressive 46 Plicera 46 alvespimycin 46 synaptogenesis 46 parietal cortices 46 childhood acute lymphoblastic 46 JANUVIA 46 Uveal melanoma 46 mg/m2 administered 46 interobserver 46 limiting toxicity 46 SGAs 46 Muscarinic 46 neuronal nitric oxide synthase 46 sulphonylurea 46 tapentadol 46 BioGard 46 prefrontal brain 46 pharmacodynamic markers 46 genomic rearrangement 46 colon carcinogenesis 46 R#/MEM # 46 dosage regimens 46 Lipitor #mg 46 budesonide inhalation suspension 46 events SAEs 46 Comorbidity 46 Panzem R NCD 46 Laquinimod 46 triazolam 46 Singh Manoux 46 nonprogressive 46 non selective NSAIDs 46 synaptic function 46 ATD Gel 46 lintuzumab SGN 46 phenotypic differences 46 veltuzumab 46 CNTNAP2 46 Blinatumomab 46 glatiramer acetate GA 46 pitavastatin 46 protein conformation 46 Inhalation Powder 46 KADIAN R 46 mg Pycnogenol 46 commercialized DURECT 46 missense mutations 45 refractory NSCLC 45 dose limiting toxicities 45 IgG1 antibodies 45 immunologic responses 45 plus COPEGUS 45 melphalan prednisone 45 bronchodilator therapy 45 Alpha Tocopherol Beta Carotene 45 AChE inhibitors 45 anthracycline therapy 45 NVA# 45 behavioral disturbances 45 X4 viruses 45 mapatumumab 45 Milnacipran 45 Nicole Onetto MD 45 liposomal formulation 45 ceftriaxone 45 danoprevir 45 HCV protease 45 immunosuppressant 45 B streptococcal 45 fibrates 45 Phenotypic 45 coexistent 45 neurocognition 45 oligomeric 45 Androxal ® 45 pathophysiological 45 UACR 45 administered systemically 45 inecalcitol 45 Neurodex 45 TRPV1 agonist 45 dysregulation 45 nongenetic 45 transcriptional activity 45 ASONEP 45 naïve HCV 45 vinorelbine 45 ELND# 45 nociceptive 45 Aurora kinase inhibitor 45 mg/# h 45 tic severity 45 ABO blood 45 sub syndromal 45 neuropathologic 45 FOR AN OPEN 45 alpha secretase 45 GABAB receptors 45 lisdexamfetamine dimesylate 45 sedatives hypnotics 45 subsyndromal 45 pathophysiological mechanisms 45 systemic absorption 45 LTRAs 45 dopamine D2 receptors 45 Cell Non Hodgkin 45 mg kg dose 45 severe hepatic impairment 45 striatal dopamine 45 hypertension pulmonary arterial 45 highly immunogenic 45 neuroendocrine 45 HGS ETR2 45 ganetespib 45 symptom exacerbation 45 Apolipoprotein AI 45 CD4 monoclonal antibody 45 dosed orally 44 periprocedural MI